| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,946 |
1,451 |
$249K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,497 |
1,210 |
$70K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,277 |
1,031 |
$65K |
| 87634 |
|
1,594 |
1,352 |
$59K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,282 |
1,642 |
$59K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,858 |
1,363 |
$57K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,105 |
1,569 |
$35K |
| 87581 |
|
1,953 |
1,454 |
$32K |
| 87486 |
|
1,862 |
1,364 |
$32K |
| 87640 |
|
1,883 |
1,604 |
$30K |
| 87498 |
|
1,596 |
1,350 |
$27K |
| 87641 |
|
1,142 |
1,098 |
$21K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
489 |
244 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,175 |
813 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
37 |
36 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
569 |
339 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
383 |
289 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
885 |
581 |
$4K |
| 87541 |
|
214 |
209 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
252 |
164 |
$2K |
| 87500 |
|
40 |
38 |
$784.22 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
27 |
12 |
$426.48 |
| 84703 |
|
97 |
84 |
$419.24 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
18 |
17 |
$321.31 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
655 |
535 |
$199.90 |
| 80051 |
|
60 |
23 |
$149.25 |
| 81003 |
|
75 |
54 |
$130.34 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
19 |
12 |
$81.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
382 |
304 |
$31.12 |
| 3074F |
|
990 |
934 |
$0.00 |
| 3079F |
|
129 |
124 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
607 |
560 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
522 |
499 |
$0.00 |
| 3075F |
|
44 |
43 |
$0.00 |
| 3078F |
|
869 |
826 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,505 |
1,400 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
730 |
688 |
$0.00 |
| 87999 |
|
583 |
558 |
$0.00 |